Systematic evidence-based clinical practice guidelines are ushering in a new stage of standardized management of hepatocellular carcinoma in Japan.

Song PP, Tang W, Hasegawa K, Kokudo N

Drug Discov Ther. 2014; 8(2):64-70.

DOI: 10.5582/ddt.8.64

Summary Full Text (PDF)

Daily hydroxyl radical scavenging capacity of mammals.

Ienaga K, Park CH, Yokozawa T

Drug Discov Ther. 2014; 8(2):71-75.

DOI: 10.5582/ddt.8.71

Summary Full Text (PDF)

Design, synthesis and biological evaluation of 4-chromanone derivatives as I_Kr inhibitors.

Wang R, Liu ZZ, Du LP, Li MY

Drug Discov Ther. 2014; 8(2):76-83.

DOI: 10.5582/ddt.8.76

Summary Full Text (PDF)

Metabolites from Aspergillus versicolor, an endolichenic fungus from the lichen Lobaria retigera.

Dou YL, Wang XL, Jiang DF, Wang HY, Jiao Y, Lou HX, Wang XN

Drug Discov Ther. 2014; 8(2):84-88.

DOI: 10.5582/ddt.8.84

Summary Full Text (PDF)

Exploring the influence of renal dysfunction on the pharmacokinetics of ribavirin after oral and intravenous dosing.

Gupta SK, Kantesaria B, Glue P

Drug Discov Ther. 2014; 8(2):89-95.

DOI: 10.5582/ddt.8.89

Summary Full Text (PDF)

Three-dimensional imaging technology offers promise in medicine.

Karako K, Wu Q, Gao JJ

Drug Discov Ther. 2014; 8(2):96-97.

DOI: 10.5582/ddt.8.96

Summary Full Text (PDF)

Current clinical uses of the biomarkers for hepatocellular carcinoma.

Huang JW, Zeng Y

Drug Discov Ther. 2014; 8(2):98-99.

DOI: 10.5582/ddt.8.98

Summary Full Text (PDF)

Suggestions to the media to help us cope with the A/H7N9 crisis in China.

Sun Y, Lu HZ

Drug Discov Ther. 2014; 8(2):100-101.

DOI: 10.5582/ddt.8.100

Summary Full Text (PDF)